Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Pancreatic cancer, Secondary cancers
Closed
Phase 2
This trial is looking at treating pancreatic cancer that has spread to another part of the body with gemcitabine, pembrolizumab and IMM-101.
It is open to people who have:
joined the Precision-Panc trial
not had treatment for their pancreatic cancer that has spread
Cancer Research UK supports this trial.
Recruitment start: 17 June 2024
Recruitment end: 23 May 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Chang
Professor Jeff Evans
Cancer Research UK
Immodulon Therapeutics Limited
Merck, Sharp & Dohme
NHS Greater Glasgow and Clyde, University of Glasgow
Last reviewed: 2 July 2025
CRUK internal database number: 19123
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
